Skip to main content

Research Repository

Advanced Search

P084 Socioeconomic Outcomes With Ribociclib in Patients With HR+, HER2– Advanced Breast Cancer (ABC) in UK Real-world Settings

Hall, P.; Howell, S.; Venkitaraman, R.; Thomson, A.; Raja, F.; King, J.; Michie, C.; Khan, S.; Brunt, A.M.; Gahir, D.; McAdam, K.; Cooner, J.; Kane, N.

Authors

P. Hall

S. Howell

R. Venkitaraman

A. Thomson

F. Raja

J. King

C. Michie

S. Khan

D. Gahir

K. McAdam

J. Cooner

N. Kane



Citation

Hall, P., Howell, S., Venkitaraman, R., Thomson, A., Raja, F., King, J., …Kane, N. (2023, March). P084 Socioeconomic Outcomes With Ribociclib in Patients With HR+, HER2– Advanced Breast Cancer (ABC) in UK Real-world Settings. Poster presented at 18th St. Gallen International Breast Cancer Conference, Vienna, Austria

Presentation Conference Type Poster
Conference Name 18th St. Gallen International Breast Cancer Conference
Conference Location Vienna, Austria
Start Date Mar 18, 2023
End Date Mar 21, 2023
Deposit Date Jan 24, 2024
Publisher Elsevier
DOI https://doi.org/10.1016/s0960-9776%2823%2900201-1
Keywords General Medicine; Surgery
Publisher URL https://www.sciencedirect.com/science/article/pii/S0960977623002011
Additional Information This article is maintained by: Elsevier; Article Title: P084 Socioeconomic Outcomes With Ribociclib in Patients With HR+, HER2– Advanced Breast Cancer (ABC) in UK Real-world Settings; Journal Title: The Breast; CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/S0960-9776(23)00201-1; Content Type: simple-article; Copyright: Copyright © 2023 Elsevier Ltd.